Home›Search›Атеротромбоз

Атеротромбоз

«REMEDIUM GROUP» Ltd. · Russian Federation · Est. 2016

ISSN2307-1109eISSN2658-5952

✓ DOAJ✓ Open Access

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ DOAJ-listed52

Total52

Third-party records · how this is calculated · Report an error →

H-Indexi

Total Worksi

195

Total Citationsi

246

2yr Mean Citednessi

0.17

Open Impact Factor alternative

Aims & Scope✦ Inferred from recent articles

The journal focuses on the diagnosis, risk assessment, and treatment of cardiovascular diseases, particularly those involving thrombosis and atherosclerosis. It covers topics such as pulmonary embolism, deep vein thrombosis, myocardial infarction, and atrial fibrillation. The scope includes the use of anticoagulants and antiplatelet therapies, surgical interventions for vascular diseases, and the management of complications like bleeding and thromboembolism. The journal also addresses the impact of comorbidities such as diabetes and cancer on cardiovascular health and treatment outcomes.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionRussian Federation

Primary LanguageRussian

1st Year Published2016

Annual Volume~ 15 articles / year

StatusActive (last: 2024)

Total Publications195

OA Since2018

Visit Journal Website

Submission Info

Peer ReviewAnonymous peer review

Review Time—

Acceptance Rate—

OA LicenseCC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/12 · 67%

✅

Do you know the journal / publisher?

«REMEDIUM GROUP» Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2307-1109 / 2658-5952

✅

Indexed in a trusted database?

DOAJ

✅

Peer review process documented?

Anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

Russian

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2017

2018

2019

2020

2021

2022

2023

2024

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

Subject Classification

Research Topics (OpenAlex)

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchCardiac Arrhythmias and TreatmentsAortic aneurysm repair treatmentsCardiac Imaging and DiagnosticsLegal and Regulatory AnalysisLinguistic, Cultural, and Literary StudiesMilitary Technology and Strategies

Frequently asked questions about Атеротромбоз

Is Атеротромбоз a predatory journal?

PubScope has no integrity flags on record for Атеротромбоз: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Атеротромбоз?

Атеротромбоз is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its open 2-year mean citedness is 0.17.

Is Атеротромбоз indexed in Scopus and Web of Science?

Атеротромбоз is indexed in DOAJ.